CPRX logo

Catalyst Pharmaceuticals (CPRX) Working capital

annual working capital:

$502.93M+$359.67M(+251.05%)
December 31, 2024

Summary

  • As of today (June 27, 2025), CPRX annual working capital is $502.93 million, with the most recent change of +$359.67 million (+251.05%) on December 31, 2024.
  • During the last 3 years, CPRX annual working capital has risen by +$319.89 million (+174.76%).
  • CPRX annual working capital is now at all-time high.

Performance

CPRX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

quarterly working capital:

$574.07M+$71.14M(+14.14%)
March 31, 2025

Summary

  • As of today (June 27, 2025), CPRX quarterly working capital is $574.07 million, with the most recent change of +$71.14 million (+14.14%) on March 31, 2025.
  • Over the past year, CPRX quarterly working capital has increased by +$249.03 million (+76.62%).
  • CPRX quarterly working capital is now at all-time high.

Performance

CPRX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

CPRX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+251.1%+76.6%
3 y3 years+174.8%+189.6%
5 y5 years+476.3%+478.1%

CPRX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+251.1%at high+327.7%
5 y5-yearat high+476.3%at high+478.1%
alltimeall timeat high>+9999.0%at high>+9999.0%

CPRX Working capital History

DateAnnualQuarterly
Mar 2025
-
$574.07M(+14.1%)
Dec 2024
$502.93M(+251.0%)
$502.93M(+16.0%)
Sep 2024
-
$433.60M(+13.5%)
Jun 2024
-
$382.11M(+17.6%)
Mar 2024
-
$325.04M(+126.9%)
Dec 2023
$143.27M(-45.6%)
$143.27M(+6.7%)
Sep 2023
-
$134.21M(-28.8%)
Jun 2023
-
$188.47M(+32.5%)
Mar 2023
-
$142.20M(-46.0%)
Dec 2022
$263.22M(+43.8%)
$263.22M(+13.6%)
Sep 2022
-
$231.63M(+5.3%)
Jun 2022
-
$220.07M(+11.0%)
Mar 2022
-
$198.25M(+8.3%)
Dec 2021
$183.04M(+34.1%)
$183.04M(+6.3%)
Sep 2021
-
$172.18M(+7.5%)
Jun 2021
-
$160.17M(+8.9%)
Mar 2021
-
$147.10M(+7.8%)
Dec 2020
$136.49M(+56.4%)
$136.49M(+9.1%)
Sep 2020
-
$125.11M(+12.8%)
Jun 2020
-
$110.95M(+11.7%)
Mar 2020
-
$99.31M(+13.8%)
Dec 2019
$87.26M(+91.1%)
$87.26M(+20.2%)
Sep 2019
-
$72.60M(+25.4%)
Jun 2019
-
$57.90M(+26.3%)
Mar 2019
-
$45.84M(+0.3%)
Dec 2018
$45.68M(-43.6%)
$45.68M(-22.6%)
Sep 2018
-
$59.01M(-10.6%)
Jun 2018
-
$66.00M(-13.4%)
Mar 2018
-
$76.20M(-5.8%)
Dec 2017
$80.92M(+105.6%)
$80.92M(+155.4%)
Sep 2017
-
$31.68M(-6.6%)
Jun 2017
-
$33.91M(-4.6%)
Mar 2017
-
$35.55M(-9.7%)
Dec 2016
$39.36M(-30.3%)
$39.36M(-8.6%)
Sep 2016
-
$43.06M(-7.1%)
Jun 2016
-
$46.37M(-8.8%)
Mar 2016
-
$50.81M(-10.0%)
Dec 2015
$56.46M
$56.46M(-8.9%)
Sep 2015
-
$61.97M(-5.7%)
DateAnnualQuarterly
Jun 2015
-
$65.71M(-6.3%)
Mar 2015
-
$70.12M(+84.7%)
Dec 2014
$37.97M(+63.8%)
$37.97M(-4.7%)
Sep 2014
-
$39.83M(-8.4%)
Jun 2014
-
$43.49M(+120.4%)
Mar 2014
-
$19.73M(-14.9%)
Dec 2013
$23.18M(+53.7%)
$23.18M(-9.6%)
Sep 2013
-
$25.63M(+136.3%)
Jun 2013
-
$10.85M(-19.2%)
Mar 2013
-
$13.42M(-11.0%)
Dec 2012
$15.08M(+179.5%)
$15.08M(+33.1%)
Sep 2012
-
$11.33M(+61.8%)
Jun 2012
-
$7.00M(+71.4%)
Mar 2012
-
$4.09M(-24.3%)
Dec 2011
$5.39M(-1.5%)
$5.39M(+40.2%)
Sep 2011
-
$3.85M(-21.8%)
Jun 2011
-
$4.92M(-21.2%)
Mar 2011
-
$6.24M(+13.9%)
Dec 2010
$5.48M(-27.9%)
$5.48M(-8.1%)
Sep 2010
-
$5.96M(+10.5%)
Jun 2010
-
$5.39M(-18.6%)
Mar 2010
-
$6.63M(-12.7%)
Dec 2009
$7.59M(-27.6%)
$7.59M(+60.6%)
Sep 2009
-
$4.73M(-20.1%)
Jun 2009
-
$5.92M(-22.2%)
Mar 2009
-
$7.61M(-27.4%)
Dec 2008
$10.49M(-35.4%)
$10.49M(-25.1%)
Sep 2008
-
$14.00M(+10.6%)
Jun 2008
-
$12.66M(-15.1%)
Mar 2008
-
$14.90M(-8.2%)
Dec 2007
$16.23M(-18.1%)
$16.23M(-4.8%)
Sep 2007
-
$17.04M(-4.0%)
Jun 2007
-
$17.76M(-5.6%)
Mar 2007
-
$18.81M(-5.1%)
Dec 2006
$19.82M(+4523.2%)
$19.82M(+754.0%)
Sep 2006
-
$2.32M(-2256.3%)
Jun 2006
-
-$107.60K(-125.1%)
Dec 2005
$428.60K(+269.2%)
$428.60K(+269.2%)
Dec 2004
$116.10K
$116.10K

FAQ

  • What is Catalyst Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual working capital year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly working capital year-on-year change?

What is Catalyst Pharmaceuticals annual working capital?

The current annual working capital of CPRX is $502.93M

What is the all time high annual working capital for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual working capital is $502.93M

What is Catalyst Pharmaceuticals annual working capital year-on-year change?

Over the past year, CPRX annual working capital has changed by +$359.67M (+251.05%)

What is Catalyst Pharmaceuticals quarterly working capital?

The current quarterly working capital of CPRX is $574.07M

What is the all time high quarterly working capital for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly working capital is $574.07M

What is Catalyst Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, CPRX quarterly working capital has changed by +$249.03M (+76.62%)
On this page